Functional genotype classification groups distinguish disease severity in recessive dystrophic epidermolysis bullosa. [PDF]
Pathmarajah P +24 more
europepmc +1 more source
Inflammatory modulation by cord blood stem cells prevented digit deformation in recessive dystrophic epidermolysis bullosa. [PDF]
Anderson-Crannage M +12 more
europepmc +1 more source
Results of a non-randomized, open-label phase I study evaluating the novel immunomodulatory peptide TCP-25 for treatment of dystrophic epidermolysis bullosa. [PDF]
Wallblom K +8 more
europepmc +1 more source
Human urine-derived stem cells rescue cutaneous manifestation and suppress inflammation and fibrosis <i>in vitro</i> and in a mouse model of recessive dystrophic epidermolysis bullosa. [PDF]
Zhou X +15 more
europepmc +1 more source
The Role of Fibroblasts in Dystrophic Epidermolysis Bullosa Pathogenesis and Current Treatment Approaches. [PDF]
Nyström A, Pattaroni C, Kern JS.
europepmc +1 more source
Natural history study of recessive dystrophic epidermolysis bullosa wounds and patient reported outcomes using mobile application home photography. [PDF]
Fulchand S +9 more
europepmc +1 more source
Dystrophic epidermolysis bullosa caused by novel frameshift mutation in the <i>COL7A1</i> gene: A case report. [PDF]
Yang Y, Guan ZW, Li QF.
europepmc +1 more source
Systems immunology integrates the complex endotypes of recessive dystrophic epidermolysis bullosa. [PDF]
Hirt N +15 more
europepmc +1 more source
Efficacy and Safety of the Topical Gene Therapy Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Study of Japanese Subjects With Dystrophic Epidermolysis Bullosa. [PDF]
Natsuga K +12 more
europepmc +1 more source
Cross-sectional analysis of wound-associated soluble factors in early, established, and chronic wounds of recessive dystrophic epidermolysis bullosa patients. [PDF]
Alexeev V +7 more
europepmc +1 more source

